By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
Kamada Ltd. (KMDA) Reports Final Results From Phase 2/3 Clinical Trial Of Inhaled Alpha-1 Antitrypsin To Treat Alpha-1 Antitrypsin Deficiency 9/4/2014 11:38:00 AM
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014 8:10:08 AM
Kamada Ltd. (KMDA) To Host Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/6/2014 9:27:49 AM
Kamada Ltd. (KMDA) Crashes After Key Trial Failure 5/16/2014 7:57:40 AM
Kamada Ltd. (KMDA.TA) To Announce Results From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency On May 16 5/15/2014 9:23:47 AM
Kamada Ltd. (KMDA.TA) Reports First Quarter Financial Results 5/8/2014 9:27:08 AM
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia® 4/24/2014 6:59:59 AM
Kamada Ltd. (KMDA.TA) Announces U.S. Proof-Of-Concept Study With Glassia® For Graft-Versus-Host Disease 4/3/2014 9:23:56 AM
Kamada Ltd. (KMDA.TA) Announces Initiation Of A Phase 2 U.S. Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 3/24/2014 7:49:04 AM
Kamada Ltd. (KMDA.TA) To Report Top-Line Data From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency By Late April Or Early May 3/21/2014 8:55:34 AM
123456789
//-->